Emzeltrectinib

DB21605ExperimentalSmall molecule

Emzeltrectinib is a small molecule drug. The usage of the INN stem '-trectinib' in the name indicates that Emzeltrectinib is a tropomyosin receptor kinase (TRK) inhibitor. Emzeltrectinib has a monoisotopic...

Chemical structure of Emzeltrectinib
Formula / weight
C17H15F3N6O ยท 376.343 g/mol (avg)

Resolves to

Compound
UNII436Z4BZ8HFCAS2223678-97-3ChEMBLCHEMBL5314458
Structure
InChIKeyYFTARXQOKASKBW-JOYOIKCWSA-NSMILESNC(=O)C1=C2N=C(C=CN2N=C1N)N1C[C@@H](F)C[C@@H]1C1=C(F)C=CC(F)=C1

Which companies are running trials of Emzeltrectinib, in which indications and phases, and which of those programs are still active?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In